Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.
- Published In:
- Pflugers Archiv : European journal of physiology, 476(5), 779-795 (2024)
- Authors:
- Moghazy, Hoda M, Abdelhaliem, Nesreen G, Mohammed, Sherine Ahmed, Hassan, Asmaa, Abdelrahman, Amany
- Database ID:
- RPEP-08884
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08884APA
Moghazy, Hoda M; Abdelhaliem, Nesreen G; Mohammed, Sherine Ahmed; Hassan, Asmaa; Abdelrahman, Amany. (2024). Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.. Pflugers Archiv : European journal of physiology, 476(5), 779-795. https://doi.org/10.1007/s00424-024-02933-0
MLA
Moghazy, Hoda M, et al. "Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.." Pflugers Archiv : European journal of physiology, 2024. https://doi.org/10.1007/s00424-024-02933-0
RethinkPeptides
RethinkPeptides Research Database. "Liraglutide versus pramlintide in protecting against cogniti..." RPEP-08884. Retrieved from https://rethinkpeptides.com/research/moghazy-2024-liraglutide-versus-pramlintide-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.